Nurix Therapeutics Inc (NRIX)

Stock-Based Compensation

$10.78M

Quarterly · Period ending: · USD

NRIX logo

NRIX Stock-Based Compensation

Latest reported$10.78M
NRIX Quarterly Stock-Based Comp ($102.00K → $10.78M)
High-resolution chart · PNG

NRIX stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nurix Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
10,777,000
11,388,000
9,404,000
9,086,000
9,772,000
10,385,000
8,722,000
8,508,000
8,754,000
8,845,000
7,822,000
8,024,000
8,445,000
8,723,000
8,481,000
8,297,000
6,988,000
6,775,000
6,071,000
4,843,000
4,313,000
3,944,000
2,700,000
2,536,000
1,115,000
474,000
176,000
167,000
136,000
105,000
102,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.